|
|
|
| home > white papers > Achieve full compliance with tamper-verification pharma solutions - UPM Raflatac |
|
|
 WHITE PAPERS |
|
UPM Raflatac
|
|
Achieve full compliance with tamper-verification pharma solutions
|
|
UPM Raflatac has developed a range of pharmaceutical labelling products to support compliance with the Falsified Medicines Directive on packaging for prescription drugs and high-risk, over-the-counter medicines. Few solutions offer the same ease of adoption for meeting the February 2019 deadline.
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
AstraZeneca Expands Role in Rare Disease by Acquiring Alexion Pharmaceuticals
Today marks the beginning of Alexion’s next chapter, with the exciting
news that we have been acquired by AstraZeneca, a global, science-led
biopharmaceutical company. This development also marks the creation of
Alexion, AstraZeneca Rare Disease.
More info >> |
|
 |
White Papers |
 |
|
Optimize your Biologic’s Analytical Program for Greater Risk Reduction
Merck
Analytical methods are used throughout upstream and downstream processes to help ensure the desired molecule is being produced with the desired purity. In addition to having the right molecule, quality must be confirmed in terms of glycosylation, oxidation, aggregates, activity and concentration. The analytical package must also ensure that all impurities from the manufacturing process and environment are consistently removed.
More info >> |
|
 |
Industry Events |
 |
Pharma Integrates 2021
16 November 2021, VIRTUAL CONFERENCE
Now in its tenth year, Pharma Integrates is a unique event bringing
together pharma and healthcare leaders across the Pharmaceutical
pipeline to address their needs, to share insights and create debate on
crucial topics that influence the future of patient outcomes.
More info >> |
|
|
|
